Engineered strain of
View Patent ↗Methods and systems for producing prescribed unit size azido-poly(3-hydroxyalkanoate) (azido-PHA) polymers and copolymers are provided. The methods and systems can employ recombinant bacteria that are not native producers of PHA or lack enzymes to degrade PHA once synthesized, metabolize short to long chain fatty acids without induction, and express an (R)-specific enoyl-CoA hydratase and a PHA synthase, the (R)-specific enoyl-CoA hydratase and PHA synthase having wide substrate specificities. The recombinant bacteria are fed at least one ω-azidofatty acid substrate that is equal in carbon length to the prescribed or desired unit size of an azido-PHA polymer to be produced. Azido-PHA polymers or azido-PHA co-polymers can be conjugated via copper-catalyzed alkyne-azide cycloaddition (CuAAC) or strain-promoted azide-alkyne cycloaddition (SPAAC) reactions. The prescribed unit size conjugated azido-PHA polymer or orthogonally conjugated azido-PHA co-polymer that is produced is then isolated and/or purified.
1. A system for producing a prescribed unit size azido-poly(3-hydroxyalkanoate) (azido-PHA) polymer comprising a recombinant bacterium, wherein the bacterium:
a. metabolizes short to long chain fatty acids without induction, and
b. expresses an (R)-specific enoyl-CoA hydratase and a PHA synthase, wherein the bacterium is fed a fatty acid substrate, wherein the fatty acid substrate is a ω-azido-fatty acid substrate, the ω-azido-fatty acid comprising a terminal azide, and the ω-azido-fatty acid being of equal carbon length to the prescribed unit size of the azido-PHA polymer to be produced.
2. The system of claim 1 , wherein the bacterium is not a native or natural producer of PHA or lacks enzymes to degrade PHA once synthesized.
3. The system of claim 1 , wherein the recombinant bacterium is a recombinant E. coli.
4. The system of claim 1 , wherein the recombinant bacterium comprises a plasmid comprising an (R)-specific enoyl-CoA hydratase gene and a PHA synthase gene.